Who is the owner of Dr Reddys?
K. Anji Reddy. Scientist, entrepreneur and philanthropist, Dr. K Anji Reddy’s passion for drug discovery and his pioneering contributions to making medicines affordable are legendary.
When was Dr Reddy’s Laboratories established?
1984
Dr. Reddy’s Laboratories/Founded
Dr Reddy’s Laboratories was incorporated in the year 1984 in Hyderabad. The company was established by Dr Anji Reddy with an initial capital outlay of Rs 25 lakh.
Who is the current chief financial officer of Dr Reddy’s lab?
SAUMEN CHAKRABORTY PRESIDENT& CFO, DR REDDY’SLABORATORIES ally, he is also responsible for the organisation’s Information Technology function & Business Process Excellence.
Why are biologics important to Dr Reddy’s Laboratories?
Biologics Accelerate global access to high-quality and affordable Biologics. At Dr Reddy’s, we constantly strive to bring the most advanced medicines within the reach of millions around the world. The efforts at our Biologics division, working on high quality global biosimilars for the last fifteen years, are a testament to that commitment.
How big is Dr Reddy’s research and Development Center?
At the heart of our research and development organization is our state-of-the-art R&D Center spread over 300,000 sq. ft. The Center houses over 70 laboratories and has over 800 research scientists working on various projects. This R&D Center works in close conjunction with other centers across the UK and the Netherlands.
What are the strengths of Dr Reddy’s Laboratories?
Investor Presentation – 2016 Dr. Reddy’s Laboratories Ltd. 9 Key strengths and capabilities Industry leading chemistry skills Several niche product opportunities (tacrolimus , metoprolol succinate, azacitidine, divalproex sodium ER, sumatriptan auto-injector)
What kind of business model does Dr Reddy’s have?
Investor Presentation – 2016 Dr. Reddy’s Laboratories Ltd. 8 We have a vertically integrated business model with three distinct segments Global Generics •Amongst the leaders in supply of generic APIs globally •Customers include generic manufacturers, innovator companies Pharmaceutical Services & Active Ingredients